{
  "run_id": "8ccefacb-370b-49d2-a2af-7b582b0fb7c6",
  "prompt_variant_id": "e63c1ef1-c646-4205-ac3f-d0b67fd4b3d4",
  "api_config_name": "model_deepseek_chat",
  "test_case_id": "breast_cancer_her2_positive",
  "start_time": "2025-09-01T14:03:19.958636",
  "end_time": "2025-09-01T14:03:22.900781",
  "duration_ms": 2926.079034805298,
  "success": true,
  "error_message": "",
  "entities_extracted": 16,
  "entities_mapped": 14,
  "extraction_completeness": 1.0,
  "mapping_accuracy": 0.6,
  "precision": 0.8235294117647058,
  "recall": 0.875,
  "f1_score": 0.8484848484848485,
  "compliance_score": 1.0,
  "token_usage": 3382,
  "extracted_entities": [
    {
      "text": "HER2-Positive Breast Cancer",
      "type": "condition",
      "attributes": {
        "status": "positive"
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "conditionsModule",
        "section_type": "conditions",
        "document_id": "unknown"
      }
    },
    {
      "text": "Metastatic Breast Cancer",
      "type": "condition",
      "attributes": {
        "status": "positive"
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "conditionsModule",
        "section_type": "conditions",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-positive metastatic breast cancer",
      "type": "condition",
      "attributes": {
        "status": "positive"
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Measurable disease per RECIST 1.1",
      "type": "condition",
      "attributes": {
        "status": "positive"
      },
      "confidence": 0.9,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "ECOG performance status 0-1",
      "type": "demographic",
      "attributes": {
        "value": "0-1",
        "unit": "ECOG scale"
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Adequate organ function",
      "type": "condition",
      "attributes": {
        "status": "positive"
      },
      "confidence": 0.85,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Prior treatment with Trastuzumab Deruxtecan",
      "type": "exclusion",
      "attributes": {
        "status": "negative"
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Active brain metastases",
      "type": "exclusion",
      "attributes": {
        "status": "negative"
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "Pregnancy or breastfeeding",
      "type": "exclusion",
      "attributes": {
        "status": "negative"
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "eligibilityModule",
        "section_type": "eligibility",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-positive metastatic breast cancer",
      "type": "condition",
      "attributes": {
        "status": "positive"
      },
      "confidence": 1.0,
      "source_context": {
        "section_name": "descriptionModule",
        "section_type": "description",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-targeted therapy",
      "type": "biomarker",
      "attributes": {
        "status": "positive"
      },
      "confidence": 1.0,
      "source_context": {
        "section_name": "descriptionModule",
        "section_type": "description",
        "document_id": "unknown"
      }
    },
    {
      "text": "trastuzumab-based therapy",
      "type": "biomarker",
      "attributes": {
        "status": "positive"
      },
      "confidence": 1.0,
      "source_context": {
        "section_name": "descriptionModule",
        "section_type": "description",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-Positive",
      "type": "biomarker",
      "attributes": {
        "status": "positive"
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "identificationModule",
        "section_type": "identification",
        "document_id": "unknown"
      }
    },
    {
      "text": "Breast Cancer",
      "type": "condition",
      "attributes": {},
      "confidence": 0.98,
      "source_context": {
        "section_name": "identificationModule",
        "section_type": "identification",
        "document_id": "unknown"
      }
    },
    {
      "text": "HER2-Positive",
      "type": "biomarker",
      "attributes": {
        "status": "positive"
      },
      "confidence": 0.95,
      "source_context": {
        "section_name": "identificationModule",
        "section_type": "identification",
        "document_id": "unknown"
      }
    },
    {
      "text": "Metastatic Breast Cancer",
      "type": "condition",
      "attributes": {},
      "confidence": 0.98,
      "source_context": {
        "section_name": "identificationModule",
        "section_type": "identification",
        "document_id": "unknown"
      }
    }
  ],
  "mcode_mappings": [
    {
      "resourceType": "Condition",
      "mcode_element": "CancerCondition",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancercondition",
        "display": "CancerCondition"
      },
      "value": "HER2-positive breast cancer",
      "mapping_confidence": 0.95,
      "source_text_fragment": "Entity index 0",
      "mapping_rationale": "Direct match to cancer condition with HER2 biomarker status",
      "id": "1c9492ba-d2f5-4a73-8c60-f3d5b0b864a3",
      "llm_source_text_fragment": "Entity index 0",
      "source_references": []
    },
    {
      "resourceType": "Condition",
      "mcode_element": "CancerCondition",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancercondition",
        "display": "CancerCondition"
      },
      "value": "Metastatic breast cancer",
      "mapping_confidence": 0.95,
      "source_text_fragment": "Entity index 1",
      "mapping_rationale": "Direct match to metastatic cancer condition",
      "id": "be572886-1488-44f6-95bd-95a999845912",
      "llm_source_text_fragment": "Entity index 1",
      "source_references": []
    },
    {
      "resourceType": "Condition",
      "mcode_element": "CancerCondition",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancercondition",
        "display": "CancerCondition"
      },
      "value": "HER2-positive metastatic breast cancer",
      "mapping_confidence": 0.95,
      "source_text_fragment": "Entity index 2",
      "mapping_rationale": "Specific cancer condition with metastatic status and biomarker",
      "id": "02c3944e-3a1e-4b51-baac-7761f1fb8705",
      "llm_source_text_fragment": "Entity index 2",
      "source_references": []
    },
    {
      "resourceType": "Observation",
      "mcode_element": "CancerDiseaseStatus",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancerdiseasestatus",
        "display": "CancerDiseaseStatus"
      },
      "value": "active",
      "mapping_confidence": 0.85,
      "source_text_fragment": "Entity index 3",
      "mapping_rationale": "Measurable disease per RECIST 1.1 indicates active disease status",
      "id": "3ecbb1c2-f9e5-452c-8d61-a333191db801",
      "llm_source_text_fragment": "Entity index 3",
      "source_references": []
    },
    {
      "resourceType": "Observation",
      "mcode_element": "ECOGPerformanceStatus",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "ecogperformancestatus",
        "display": "ECOGPerformanceStatus"
      },
      "value": "0-1",
      "mapping_confidence": 0.95,
      "source_text_fragment": "Entity index 4",
      "mapping_rationale": "Direct match to ECOG performance status scale",
      "id": "42c35b77-fb45-474d-a71c-619700d78d85",
      "llm_source_text_fragment": "Entity index 4",
      "source_references": []
    },
    {
      "resourceType": "MedicationStatement",
      "mcode_element": "CancerRelatedMedication",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancerrelatedmedication",
        "display": "CancerRelatedMedication"
      },
      "value": "Trastuzumab Deruxtecan",
      "mapping_confidence": 0.9,
      "source_text_fragment": "Entity index 6",
      "mapping_rationale": "HER2-targeted therapy medication, mapped as exclusion due to negative status",
      "id": "2cc66ef2-98da-4528-8f71-da5ade01db4b",
      "llm_source_text_fragment": "Entity index 6",
      "source_references": []
    },
    {
      "resourceType": "Observation",
      "mcode_element": "CancerDiseaseStatus",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancerdiseasestatus",
        "display": "CancerDiseaseStatus"
      },
      "value": "active",
      "mapping_confidence": 0.8,
      "source_text_fragment": "Entity index 7",
      "mapping_rationale": "Brain metastases indicate active disease, mapped as exclusion due to negative status",
      "id": "41fa96eb-518b-4eb0-87ee-61224c796817",
      "llm_source_text_fragment": "Entity index 7",
      "source_references": []
    },
    {
      "resourceType": "Condition",
      "mcode_element": "CancerCondition",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancercondition",
        "display": "CancerCondition"
      },
      "value": "HER2-positive metastatic breast cancer",
      "mapping_confidence": 1.0,
      "source_text_fragment": "Entity index 10",
      "mapping_rationale": "Exact match to cancer condition with biomarker and metastatic status",
      "id": "8784c4dc-bc20-4cc0-a348-484c353d1144",
      "llm_source_text_fragment": "Entity index 10",
      "source_references": []
    },
    {
      "resourceType": "Observation",
      "mcode_element": "GenomicVariant",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "genomicvariant",
        "display": "GenomicVariant"
      },
      "value": "HER2-positive",
      "mapping_confidence": 0.9,
      "source_text_fragment": "Entity index 11",
      "mapping_rationale": "HER2 biomarker status indicating genomic variant",
      "id": "6269c4d4-bf92-4fd9-bab1-defcaafed987",
      "llm_source_text_fragment": "Entity index 11",
      "source_references": []
    },
    {
      "resourceType": "MedicationStatement",
      "mcode_element": "CancerRelatedMedication",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancerrelatedmedication",
        "display": "CancerRelatedMedication"
      },
      "value": "trastuzumab",
      "mapping_confidence": 0.9,
      "source_text_fragment": "Entity index 12",
      "mapping_rationale": "HER2-targeted therapy medication",
      "id": "94aecca5-c6de-436d-86b6-4f373a7e58af",
      "llm_source_text_fragment": "Entity index 12",
      "source_references": []
    },
    {
      "resourceType": "Observation",
      "mcode_element": "GenomicVariant",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "genomicvariant",
        "display": "GenomicVariant"
      },
      "value": "HER2-positive",
      "mapping_confidence": 0.95,
      "source_text_fragment": "Entity index 13",
      "mapping_rationale": "HER2 biomarker status indicating genomic variant",
      "id": "a5fbd6d4-4476-447a-afbb-71616ee76d89",
      "llm_source_text_fragment": "Entity index 13",
      "source_references": []
    },
    {
      "resourceType": "Condition",
      "mcode_element": "CancerCondition",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancercondition",
        "display": "CancerCondition"
      },
      "value": "Breast cancer",
      "mapping_confidence": 0.98,
      "source_text_fragment": "Entity index 14",
      "mapping_rationale": "Direct match to cancer condition",
      "id": "12909806-0d31-48e4-aba8-3135d421b073",
      "llm_source_text_fragment": "Entity index 14",
      "source_references": []
    },
    {
      "resourceType": "Observation",
      "mcode_element": "GenomicVariant",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "genomicvariant",
        "display": "GenomicVariant"
      },
      "value": "HER2-positive",
      "mapping_confidence": 0.95,
      "source_text_fragment": "Entity index 15",
      "mapping_rationale": "HER2 biomarker status indicating genomic variant",
      "id": "fcc15145-75bd-4011-bdf8-412942ba8278",
      "llm_source_text_fragment": "Entity index 15",
      "source_references": []
    },
    {
      "resourceType": "Condition",
      "mcode_element": "CancerCondition",
      "code": {
        "system": "http://hl7.org/fhir/us/mcode",
        "code": "cancercondition",
        "display": "CancerCondition"
      },
      "value": "Metastatic breast cancer",
      "mapping_confidence": 0.98,
      "source_text_fragment": "Entity index 16",
      "mapping_rationale": "Direct match to metastatic cancer condition",
      "id": "2dbc858c-e9e6-488a-b2be-947b08bd1eb1",
      "llm_source_text_fragment": "Entity index 16",
      "source_references": []
    }
  ],
  "validation_results": {
    "valid": true,
    "errors": [],
    "warnings": [],
    "compliance_score": 1.0
  }
}